Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNE1 | P24864 | 20/20 | 0.51 |
| ▸ | CDK2 | P24941 | 20/20 | 0.51 |
| ▸ | CDK1 | P06493 | 5/20 | 0.51 |
| ▸ | CCNB1 | P14635 | 5/20 | 0.51 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.51 |
| ▸ | CCNE2 | O96020 | 1/20 | 0.51 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.51 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.51 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.51 |
| ▸ | CCND1 | P24385 | 14/20 | 0.46 |
| ▸ | CDK6 | Q00534 | 14/20 | 0.46 |
| ▸ | CDK4 | P11802 | 4/20 | 0.45 |
| ▸ | CCND3 | P30281 | 4/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24677069 | 1.00 | CCNE1 (0.51) | CCNE1CDK2CDK1CCNB1CCNB2 | |
| SCHEMBL24676522 | 1.00 | CCNE1 (0.51) | CCNE1CDK2CDK1CCNB1CCNB2 | |
| SCHEMBL24676433 | 0.95 | CDK2 (0.53) | CCNE1CDK2CDK1CCNB1CCNB2 | |
| SCHEMBL24676835 | 0.95 | CDK2 (0.53) | CCNE1CDK2CDK1CCNB1CCNB2 | |
| SCHEMBL24676514 | 0.95 | CDK2 (0.53) | CCNE1CDK2CDK1CCNB1CCNB2 | |
| SCHEMBL24676544 | 0.95 | CDK2 (0.53) | CCNE1CDK2CDK1CCNB1CCNB2 | |
| SCHEMBL24676661 | 0.93 | CDK2 (0.57) | CCNE1CDK2CDK1CCNB1CCNB2 | |
| SCHEMBL29754975 | 0.90 | CDK2 (0.49) | CCNE1CDK2CDK1CCNB1CCNB2 | |
| SCHEMBL24677033 | 0.90 | CDK2 (0.51) | CCNE1CDK2CDK1CCNB1CCNB2 | |
| SCHEMBL24677032 | 0.90 | CDK2 (0.51) | CCNE1CDK2CDK1CCNB1CCNB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022155941-A1 | CDK2 INHIBITORS | QILU REGOR THERAPEUTICS INC. (CN) | 2022-07-28 | — | — | WO | disclosed |
| WO-2022155941-A1 | CDK2 INHIBITORS | QILU REGOR THERAPEUTICS INC. (CN) | 2022-07-28 | — | — | WO | disclosed |